Cell Therapy Technologies Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Cell Therapy Technologies Market Through 2025?
The market size for cell therapy technologies has seen a swift expansion in the last few years, surging from $4.92 billion in 2024 to $5.67 billion in 2025 with a compound annual growth rate (CAGR) of 15.4%. This substantial development during the historical period is credited to the dynamic economic progression in fledgling markets, escalated spends on healthcare, an upsurge in government investments in cell-based study, and the rising demand for personalized medicine.

What's the Projected Size of the Global Cell Therapy Technologies Market by 2029?
Anticipated to experience swift expansion in the upcoming years, the market size of cell therapy technologies is predicted to hit $9.87 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.9%. The projected growth during the forecast period can be linked to a rising elderly population, a growing number of cancer cases, substantial R&D investments in the pharmaceutical sector, and advancements in cell-based therapies. Prominent trends during the forecast phase are proliferation of inventive products, incorporation of cutting-edge technologies, creation of innovative cell treatments, investments in manufacturing capabilities, and deliberations for partnerships and collaborations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Top Growth Drivers in the Cell Therapy Technologies Industry: What's Accelerating the Market?
The escalation in government funding for cell-based studies has influenced the expansion of the worldwide cell therapy technologies market. Governments are progressively channeling resources into research initiatives aimed at devising treatment methods for illnesses such as cancer, cardiovascular disease (CVD), among others. For example, in May 2022, The California Institute for Regenerative Medicine (CIRM), a research facility that supports stem cell research, poured in over $11 million to bankroll a clinical trial of a cell therapy designed to treat throat cancer. The triumph of this treatment could spare patients the ordeal of undergoing radiotherapy and dealing with its resultant side effects.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What Trends Will Shape the Cell Therapy Technologies Market Through 2029 and Beyond?
Major corporations in the cell therapy technologies market are working towards innovation and utilizing cutting-edge technologies to expand their market presence. For instance, In June 2022, Australia's Invetech, a company known for designing, engineering, and producing commercial-scale diagnostic products and cell and gene therapies, introduced Korus. This is a new system dedicated to autologous cell therapies, purposed to transform industry standards in elutriation and cell wash. The system employs a gentle elutriation process to provide a more refined cell population, useful for processes related to cell therapy production such as tumor-infiltrated lymphocytes (TIL), dendritic cells, chimeric antigen receptor (CAR) -T cell or induced pluripotent stem cell (IPSC)-derived therapy. The Korus system performs elutriation and cell wash via subtle counterflow centrifugation, supplying purified cell populations for downstream processing development and commercial production. It consequently enhances the overall performance of the processes due to increased recovery and purity of target cells. With the Korus system, product developers get to fast track their clinical development and product scale-up.

What Are the Main Segments in the Cell Therapy Technologies Market?
The cell therapy technologies market covered in this report is segmented -

1) By Product: Consumables, Equipment, Systems And Software
2) By Cell Type: T-Cells, Stem Cells, Other Cells
3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control
4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:
1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials
2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators
3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=4122&type=smp

Which Top Companies are Driving Growth in the Cell Therapy Technologies Market?
Major companies operating in the cell therapy technologies market include Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Huadong Medicine, Co.Don AG, AstraZeneca, Neogene Therapeutics, GammaDelta Therapeutics Limited, Nightstar, SOTIO, Accell Clinical Research, Genestack, Novartis AG, Pfizer, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bayer AG, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Amgen Brazil, GlaxoSmithKline plc, Biogen Brazil, Takeda Pharmaceutical Company Limited, Pfizer S.R.L, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Bayer East Africa Ltd, Adcock Ingram, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.

Which Regions Will Dominate the Cell Therapy Technologies Market Through 2029?
North America was the largest region in the cell therapy technologies market in 2024. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4122

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.